Cardiol Therapeutics Inc (CRDL)
1.99
+0.01
(+0.51%)
USD |
NASDAQ |
May 03, 16:00
1.99
0.00 (0.00%)
After-Hours: 20:00
Cardiol Therapeutics Price to Book Value: 6.380 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 6.380 |
May 02, 2024 | 6.348 |
May 01, 2024 | 6.605 |
April 30, 2024 | 6.445 |
April 29, 2024 | 5.675 |
April 26, 2024 | 5.739 |
April 25, 2024 | 5.900 |
April 24, 2024 | 5.643 |
April 23, 2024 | 5.900 |
April 22, 2024 | 5.643 |
April 19, 2024 | 5.675 |
April 18, 2024 | 5.354 |
April 17, 2024 | 5.611 |
April 16, 2024 | 5.515 |
April 15, 2024 | 5.739 |
April 12, 2024 | 5.964 |
April 11, 2024 | 6.284 |
April 10, 2024 | 5.996 |
April 09, 2024 | 6.156 |
April 08, 2024 | 6.028 |
April 05, 2024 | 6.092 |
April 04, 2024 | 6.541 |
April 03, 2024 | 5.900 |
April 02, 2024 | 5.803 |
April 01, 2024 | 6.156 |
Date | Value |
---|---|
March 28, 2024 | 5.555 |
March 27, 2024 | 5.525 |
March 26, 2024 | 5.586 |
March 25, 2024 | 4.481 |
March 22, 2024 | 4.542 |
March 21, 2024 | 4.696 |
March 20, 2024 | 4.757 |
March 19, 2024 | 4.665 |
March 18, 2024 | 4.604 |
March 15, 2024 | 4.665 |
March 14, 2024 | 4.358 |
March 13, 2024 | 4.542 |
March 12, 2024 | 4.481 |
March 11, 2024 | 4.266 |
March 08, 2024 | 4.604 |
March 07, 2024 | 5.003 |
March 06, 2024 | 4.803 |
March 05, 2024 | 5.463 |
March 04, 2024 | 5.402 |
March 01, 2024 | 6.016 |
February 29, 2024 | 6.323 |
February 28, 2024 | 5.678 |
February 27, 2024 | 5.279 |
February 26, 2024 | 5.402 |
February 23, 2024 | 4.972 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7204
Minimum
Nov 09 2022
12.87
Maximum
Feb 17 2021
4.104
Average
3.914
Median
Nov 15 2019
Price to Book Value Benchmarks
Aurinia Pharmaceuticals Inc | 1.930 |
Acasti Pharma Inc | 0.4302 |
Edesa Biotech Inc | 2.514 |
Lexaria Bioscience Corp | 6.185 |
Xenon Pharmaceuticals Inc | 3.558 |
Price to Book Value Related Metrics
Price | 1.99 |
Earnings Yield | -16.37% |
Market Cap | 135.85M |